Resultados globales: 17 registros encontrados en 0.02 segundos.
Artículos, Encontrados 4 registros
Documentos de investigación, Encontrados 13 registros
Artículos Encontrados 4 registros  
1.
159 p, 3.7 MB Nanomaterials for nanotheranostics : tuning their properties according to disease needs / Wong, Xin Yi (Institut Català de Nanociència i Nanotecnologia) ; Sena Torralba, Amadeo (Institut Català de Nanociència i Nanotecnologia) ; Álvarez Diduk, Ruslan (Institut Català de Nanociència i Nanotecnologia) ; Muthoosamy, Kasturi (University of Nottingham Malaysia. Centre of Nanotechnology and Advanced Materials) ; Merkoçi, Arben (Institut Català de Nanociència i Nanotecnologia)
Nanotheranostics is one of the biggest scientific breakthroughs in nanomedicine. Most of the currently available diagnosis and therapies are invasive, time-consuming, and associated with severe toxic side effects. [...]
2020 - 10.1021/acsnano.9b08133
ACS nano, Vol. 14, issue 3 (March 2020) , p. 2585-2627  
2.
10 p, 1.3 MB Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia / Bonham, L.W. (Neuroradiology Section. Department of Radiology and Biomedical Imaging. University of California. San Francisco) ; Steele, N.Z.R. (Memory and Aging Center. Department of Neurology. University of California. San Francisco) ; Karch, C.M. (Department of Psychiatry. Washington University) ; Broce, I. (Neuroradiology Section. Department of Radiology and Biomedical Imaging. University of California. San Francisco) ; Geier, E.G. (Memory and Aging Center. Department of Neurology. University of California. San Francisco) ; Wen, N.L. (Department of Psychiatry. Washington University) ; Momeni, P. (Texas Tech University Health Science Center. Laboratory of Neurogenetics) ; Hardy, J. (Department of Molecular Neuroscience. UCL Institute of Neurology) ; Miller, Z.A. (Memory and Aging Center. Department of Neurology. University of California. San Francisco) ; Gorno-Tempini, M.L. (Memory and Aging Center. Department of Neurology. University of California. San Francisco) ; Hess, C.P. (Neuroradiology Section. Department of Radiology and Biomedical Imaging. University of California. San Francisco) ; Lewis, P. (School of Pharmacy. University of Reading. Whiteknights) ; Miller, B.L. (Memory and Aging Center. Department of Neurology. University of California. San Francisco) ; Seeley, W.W. (Memory and Aging Center. Department of Neurology. University of California. San Francisco) ; Manzoni, C. (School of Pharmacy. University of Reading. Whiteknights) ; Desikan, R.S. (Neuroradiology Section. Department of Radiology and Biomedical Imaging. University of California. San Francisco) ; Baranzini, S.E. (Department of Neurology. University of California. San Francisco) ; Ferrari, R. (Department of Molecular Neuroscience. UCL Institute of Neurology) ; Yokoyama, J.S. (Memory and Aging Center. Department of Neurology. University of California. San Francisco) ; Hernandez, D.G. (Reta Lila Weston Research Laboratories. Department of Molecular Neuroscience. UCL Institute of Neurology) ; Nalls, M.A. (Laboratory of Neurogenetics. National Institute on Aging. National Institutes of Health) ; Rohrer, J.D. (Dementia Research Centre. Department of Neurodegenerative Disease. UCL Institute of Neurology) ; Ramasamy, A. (The Jenner Institute. University of Oxford) ; Kwok, J.B.J. (School of Medical Sciences. University of New South Wales) ; Dobson-Stone, C. (School of Medical Sciences. University of New South Wales) ; Schofield, P.R. (School of Medical Sciences. University of New South Wales) ; Halliday, G.M. (School of Medical Sciences. University of New South Wales) ; Hodges, J.R. (School of Medical Sciences. University of New South Wales) ; Piguet, O. (School of Medical Sciences. University of New South Wales) ; Bartley, L. (School of Medical Sciences. University of New South Wales) ; Thompson, E. (Department of Paediatrics. University of Adelaide) ; Haan, E. (Department of Paediatrics. University of Adelaide) ; Hernández, Isabel (Institut Català de Neurociènces Aplicades) ; Ruiz, A. (Institut Català de Neurociènces Aplicades) ; Boada, M. (Institut Català de Neurociènces Aplicades) ; Borroni, B. (Neurology Clinic. University of Brescia) ; Padovani, A. (Neurology Clinic. University of Brescia) ; Cruchaga, C. (Hope Center. Washington University School of Medicine) ; Cairns, N.J. (Department of Pathology and Immunology. Washington University) ; Benussi, L. (Molecular Markers Laboratory. IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Binetti, G. (MAC Memory Clinic. IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Ghidoni, R. (Molecular Markers Laboratory. IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Forloni, G. (Biology of Neurodegenerative Disorders. IRCCS Istituto di Ricerche Farmacologiche "Mario Negri") ; Albani, D. (Biology of Neurodegenerative Disorders. IRCCS Istituto di Ricerche Farmacologiche "Mario Negri") ; Galimberti, D. (Fondazione Cà Granda. IRCCS Ospedale Maggiore Policlinico) ; Fenoglio, C. (Fondazione Cà Granda. IRCCS Ospedale Maggiore Policlinico) ; Serpente, M. (Fondazione Cà Granda. IRCCS Ospedale Maggiore Policlinico) ; Scarpini, E. (Fondazione Cà Granda. IRCCS Ospedale Maggiore Policlinico) ; Clarimón, J. (Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED)) ; Lleó, Alberto (Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED)) ; Blesa, R. (Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED)) ; Landqvist Waldö, M. (Unit of Geriatric Psychiatry. Department of Clinical Sciences. Lund University) ; Nilsson, K. (Unit of Geriatric Psychiatry. Department of Clinical Sciences. Lund University) ; Nilsson, C. (Clinical Memory Research Unit. Department of Clinical Sciences. Lund University) ; Mackenzie, I.R.A. (Department of Pathology and Laboratory Medicine. University of British Columbia) ; Hsiung, G.Y.R. (Division of Neurology. University of British Columbia) ; Mann, D.M.A. (Institute of Brain. Behaviour and Mental Health. University of Manchester. Salford Royal Hospital) ; Grafman, J. (Department of Psychology. Weinberg College of Arts and Sciences. Northwestern University) ; Morris, C.M. (Institute of Neuroscience. Newcastle University Medical School) ; Attems, J. (Institute of Neuroscience and Institute for Ageing. Campus for Ageing and Vitality. Newcastle University) ; Griffiths, T.D. (Institute of Neuroscience. Newcastle University Medical School) ; McKeith, I.G. (Institute of Neuroscience and Institute for Ageing. Campus for Ageing and Vitality. Newcastle University) ; Thomas, A.J. (Institute of Neuroscience and Institute for Ageing. Campus for Ageing and Vitality. Newcastle University) ; Pietrini, P. (IMT School for Advanced Studies. Lucca) ; Huey, E.D. (Taub Institute. Departments of Psychiatry and Neurology. Columbia University) ; Wassermann, E.M. (Behavioral Neurology Unit. National Insititute of Neurological Disorders and Stroke. National Insititutes of Health) ; Baborie, A. (Department of Laboratory Medicine & Pathology. University of Alberta Edmonton) ; Jaros, E. (Institute of Neuroscience and Institute for Ageing. Campus for Ageing and Vitality. Newcastle University) ; Tierney, M.C. (Behavioral Neurology Unit. National Insititute of Neurological Disorders and Stroke. National Insititutes of Health) ; Pastor, Pau (Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED)) ; Razquin, C. (Neurogenetics Laboratory. Division of Neurosciences. Center for Applied Medical Research. Universidad de Navarra) ; Ortega-Cubero, S. (Neurogenetics Laboratory. Division of Neurosciences. Center for Applied Medical Research. Universidad de Navarra) ; Alonso, E. (Department of Neurology. Clínica Universidad de Navarra. University of Navarra School of Medicine) ; Perneczky, R. (Department of Psychiatry and Psychotherapy. Technische Universität München) ; Diehl-Schmid, J. (Department of Psychiatry and Psychotherapy. Technische Universität München) ; Alexopoulos, P. (Department of Psychiatry and Psychotherapy. Technische Universität München) ; Kurz, A. (Department of Psychiatry and Psychotherapy. Technische Universität München) ; Rainero, I. (Neurology I. Department of Neuroscience. University of Torino. Italy. A.O. Città della Salute e della Scienza di Torino) ; Rubino, E. (Neurology I. Department of Neuroscience. University of Torino. Italy. A.O. Città della Salute e della Scienza di Torino) ; Pinessi, L. (Neurology I. Department of Neuroscience. University of Torino. Italy. A.O. Città della Salute e della Scienza di Torino) ; Rogaeva, E. (Tanz Centre for Research in Neurodegenerative Diseases. University of Toronto) ; St George-Hyslop, P. (Cambridge Institute for Medical Research. and the Department of Clinical Neurosciences. University of Cambridge) ; Rossi, G. (Division of Neurology and Neuropathology. Fondazione IRCCS Istituto Neurologico Carlo Besta) ; Tagliavini, F. (Division of Neurology and Neuropathology. Fondazione IRCCS Istituto Neurologico Carlo Besta) ; Giaccone, G. (Division of Neurology and Neuropathology. Fondazione IRCCS Istituto Neurologico Carlo Besta) ; Rowe, J.B. (Behavioural and Clinical Neuroscience Institute) ; Schlachetzki, J.C.M. (University of California San Diego. Department of Cellular & Molecular Medicine) ; Uphill, J. (MRC Prion Unit. Department of Neurodegenerative Disease. UCL Institute of Neurology. Queen Square House. Queen Square) ; Collinge, J. (MRC Prion Unit. Department of Neurodegenerative Disease. UCL Institute of Neurology. Queen Square House. Queen Square) ; Mead, S. (MRC Prion Unit. Department of Neurodegenerative Disease. UCL Institute of Neurology. Queen Square House. Queen Square) ; Danek, A. (Neurologische Klinik und Poliklinik. Ludwig-Maximilians-Universität) ; Van Deerlin, V.M. (Department of Pathology and Laboratory Medicine. University of Pennsylvania Perelman School of Medicine) ; Grossman, M. (Department of Neurology and Penn Frontotemporal Degeneration Center. University of Pennsylvania Perelman School of Medicine) ; Trojanowski, J.Q. (Laboratory of Neurogenetics. Institute Born-Bunge. University of Antwerp) ; van der Zee, J. (Laboratory of Neurogenetics. Institute Born-Bunge. University of Antwerp) ; Cruts, M. (Laboratory of Neurogenetics. Institute Born-Bunge. University of Antwerp) ; Van Broeckhoven, C. (Laboratory of Neurogenetics. Institute Born-Bunge. University of Antwerp) ; Cappa, S.F. (Neurorehabilitation Unit. Department of Clinical Neuroscience. Vita-Salute University and San Raffaele Scientific Institute) ; Leber, I. (CNRS UMR 7225. F-75013) ; Hannequin, D. (Service de Neurologie. Inserm U1079. CNR-MAJ. Rouen University Hospital) ; Golfier, V. (Service de Neurologie. CH Saint Brieuc) ; Vercelletto, M. (Service de neurologie. CHU de Nantes) ; Brice, A. (CNRS UMR 7225. F-75013) ; Nacmias, B. (Department of Neurosciences. Psychology. Drug Research and Child Health (NEUROFARBA) University of Florence) ; Sorbi, S. (Department of Neurosciences. Psychology. Drug Research and Child Health (NEUROFARBA) University of Florence) ; Bagnoli, S. (Department of Neurosciences. Psychology. Drug Research and Child Health (NEUROFARBA) University of Florence) ; Piaceri, I. (Department of Neurosciences. Psychology. Drug Research and Child Health (NEUROFARBA) University of Florence) ; Nielsen, J.E. (Department of Cellular and Molecular Medicine. Section of Neurogenetics. The Panum Institute. University of Copenhagen) ; Hjermind, L.E. (Department of Cellular and Molecular Medicine. Section of Neurogenetics. The Panum Institute. University of Copenhagen) ; Riemenschneider, M. (Laboratory for Neurogenetics. Saarland University) ; Mayhaus, M. (Laboratory for Neurogenetics. Saarland University) ; Ibach, B. (Department of Psychiatry. Psychotherapy and Psychosomatics) ; Gasparoni, G. (Laboratory for Neurogenetics. Saarland University) ; Pichler, S. (Laboratory for Neurogenetics. Saarland University) ; Gu, W. (Luxembourg Centre For Systems Biomedicine (LCSB). University of Luxembourg) ; Rossor, M.N. (Dementia Research Centre. Department of Neurodegenerative Disease. UCL Institute of Neurology) ; Fox, N.C. (Dementia Research Centre. Department of Neurodegenerative Disease. UCL Institute of Neurology) ; Warren, J.D. (Dementia Research Centre. Department of Neurodegenerative Disease. UCL Institute of Neurology) ; Spillantini, M.G. (Department of Clinical Neurosciences. John Van Geest Brain Repair Centre. Forvie Site. University of Cambridge) ; Morris, H.R. (Department of Molecular Neuroscience. UCL Institute of Neurology) ; Rizzu, P. (Tübingen Site. German Center for Neurodegenerative Diseases) ; Heutink, P. (Tübingen Site. German Center for Neurodegenerative Diseases) ; Snowden, J.S. (Institute of Brain. Behaviour and Mental Health. University of Manchester. Salford Royal Hospital) ; Rollinson, S. (Institute of Brain. Behaviour and Mental Health. University of Manchester. Salford Royal Hospital) ; Richardson, A. (Salford Royal Foundation Trust. Faculty of Medical and Human Sciences. University of Manchester) ; Gerhard, A. (Institute of Brain. Behaviour and Mental Health. University of Manchester. Salford Royal Hospital) ; Bruni, A.C. (Regional Neurogenetic Centre. ASPCZ) ; Maletta, R. (Regional Neurogenetic Centre. ASPCZ) ; Frangipane, F. (Regional Neurogenetic Centre. ASPCZ) ; Cupidi, C. (Regional Neurogenetic Centre. ASPCZ) ; Bernardi, L. (Regional Neurogenetic Centre. ASPCZ) ; Anfossi, M. (Regional Neurogenetic Centre. ASPCZ) ; Gallo, M. (Regional Neurogenetic Centre. ASPCZ) ; Conidi, M.E. (Regional Neurogenetic Centre. ASPCZ) ; Smirne, N. (Regional Neurogenetic Centre. ASPCZ) ; Rademakers, R. (Department of Neuroscience. Mayo Clinic Jacksonville) ; Baker, M. (Department of Neuroscience. Mayo Clinic Jacksonville) ; Dickson, Dennis W. (Department of Neuroscience. Mayo Clinic Jacksonville) ; Graff-Radford, N.R. (Department of Neuroscience. Mayo Clinic Jacksonville) ; Petersen, R.C. (Department of Neurology. Mayo Clinic Rochester) ; Knopman, D. (Department of Neurology. Mayo Clinic Rochester) ; Josephs, K.A. (Department of Neurology. Mayo Clinic Rochester) ; Boeve, B.F. (Department of Neurology. Mayo Clinic Rochester) ; Parisi, J.E. (Department of Pathology. Mayo Clinic Rochester) ; Karydas, A.M. (Memory and Aging Center. Department of Neurology. University of California. San Francisco) ; Rosen, H. (Memory and Aging Center. Department of Neurology. University of California. San Francisco) ; van Swieten, J.C. (Department of Medical Genetics. VU university Medical Centre) ; Dopper, E.G.P. (Department of Medical Genetics. VU university Medical Centre) ; Seelaar, H. (Department of Medical Genetics. VU university Medical Centre) ; Pijnenburg, Y.A.L. (Alzheimer Centre and Department of Neurology. VU University Medical Centre) ; Scheltens, Philip (Alzheimer Centre and Department of Neurology. VU University Medical Centre) ; Logroscino, G. (Department of Basic Medical Sciences. Neurosciences and Sense Organs. "Aldo Moro" University of Bari) ; Capozzo, R. (Department of Basic Medical Sciences. Neurosciences and Sense Organs. "Aldo Moro" University of Bari) ; Novelli, V. (Medical Genetics Unit. Fondazione Policlinico Universitario A. Gemelli) ; Puca, A.A. (Department of Medicine and Surgery. University of Salerno) ; Franceschi, M. (Neurology Department. IRCCS Multimedica) ; Postiglione, A. (Department of Clinical Medicine and Surgery. University of Naples Federico II) ; Milan, G. (Geriatric Center Frullone ASL Napoli 1 Centro) ; Sorrentino, P. (Geriatric Center Frullone ASL Napoli 1 Centro) ; Kristiansen, M. (UCL Genomics. Institute of Child Health (ICH). UCL) ; Chiang, H.H. (Dept of Geriatric Medicine. Genetics Unit. Karolinska University Hospital) ; Graff, C. (Dept of Geriatric Medicine. Genetics Unit. Karolinska University Hospital) ; Pasquier, F. (Université des Sciences et Technologies de Lille. Inserm 1171. DISTALZ. CHU 59000) ; Rollin, A. (Université des Sciences et Technologies de Lille. Inserm 1171. DISTALZ. CHU 59000) ; Deramecourt, V. (Université des Sciences et Technologies de Lille. Inserm 1171. DISTALZ. CHU 59000) ; Lebouvier, T. (Université des Sciences et Technologies de Lille. Inserm 1171. DISTALZ. CHU 59000) ; Kapogiannis, D. (National Institute on Aging (NIA/NIH)) ; Ferrucci, L. (Clinical Research Branch. National Institute on Aging) ; Pickering-Brown, S. (Institute of Brain. Behaviour and Mental Health. University of Manchester. Salford Royal Hospital) ; Singleton, A.B. (Laboratory of Neurogenetics. National Institute on Aging. National Institutes of Health) ; Universitat Autònoma de Barcelona
The semantic variant of primary progressive aphasia (svPPA) is a clinical syndrome characterized by neurodegeneration and progressive loss of semantic knowledge. Unlike many other forms of frontotemporal lobar degeneration (FTLD), svPPA has a highly consistent underlying pathology composed of TDP-43 (a regulator of RNA and DNA transcription metabolism). [...]
2019 - 10.1038/s41598-019-46415-1
Scientific reports (Nature Publishing Group), Vol. 9 Núm. 1 (january 2019) , p. 10854  
3.
13 p, 3.4 MB Network-based proteomic approaches reveal the neurodegenerative, neuroprotective and pain-related mechanisms involved after retrograde axonal damage / Casas Louzao, Caty (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Isus, Laura (Institut de Recerca Biomèdica de Lleida) ; Herrando-Grabulosa, Mireia (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Mancuso, Francesco M. (Vall d'Hebron Institut d'Oncologia) ; Borrás, Eva (Universitat Pompeu Fabra. Centre de Regulació Genòmica (CRG-UPF)) ; Sabidó, Eduardo (Universitat Pompeu Fabra. Centre de Regulació Genòmica (CRG-UPF)) ; Forés Vineta, Joaquim (Hospital Clinic, CIBERehd. Department of Pathology) ; Aloy, Patrick (Institució Catalana de Recerca i Estudis Avançats (ICREA))
Neurodegenerative processes are preceded by neuronal dysfunction and synaptic disconnection. Disconnection between spinal motoneuron (MN) soma and synaptic target leads either to a retrograde degenerative process or to a regenerative reaction, depending injury proximity among other factors. [...]
2015 - 10.1038/srep09185
Scientific reports (Nature Publishing Group), Vol. 5 (2015) , art. 9185  
4.
26 p, 562.2 KB Potential Role of Olive Oil Phenolic Compounds in the Prevention of Neurodegenerative Diseases / Rodríguez-Morató, Jose (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Xicota, Laura (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Fitó, Montse (Institut Hospital del Mar d'Investigacions Mèdiques) ; Farré Albaladejo, Magí (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Dierssen, Mara (CIBER de Enfermedades Raras (CIBERER), Barcelona) ; de la Torre, Rafael (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut)
Adherence to the Mediterranean Diet (MD) has been associated with a reduced incidence of neurodegenerative diseases and better cognitive performance. Virgin olive oil, the main source of lipids in the MD, is rich in minor phenolic components, particularly hydroxytyrosol (HT). [...]
2015 - 10.3390/molecules20034655
Molecules, Vol. 20 (march 2015) , p. 4655-4680  

Documentos de investigación Encontrados 13 registros  1 - 10siguiente  ir al registro:
1.
18 p, 2.0 MB Prionoid Proteins in the Central Nervous System : both sides of the coin / Roldán Martín, Lorena ; Fernández Gallegos, Ma. Rosario (María Rosario), dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Prionoid proteins are those proteins which can have different conformations, one of which can self-perpetuate and spread within an organism, but not between individuals. Traditionally, such proteins have been related to pathological conditions, such as various neurodegenerative diseases. [...]
2018
Grau en Ciències Biomèdiques [832]  
2.
1 p, 2.3 MB Amyloids & exosomes : unravelling their functional relatioship / Santos, Jaime ; Pallarès i Goitiz, Irantzu, dir., (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2017
Grau en Biotecnologia [815]  
3.
1 p, 1.3 MB Immunology of prion neuroinvasion : importance of secondary lymphoid organs in the early stages / Bayó Llorens, Cristina ; Villaverde Corrales, Antonio, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2017
Grau en Microbiologia [816]  
4.
1 p, 2.6 MB Applications of the induced pluripotent stem cell technology in neurodegenerative diseases / Matres Rojo, Ana ; Ibáñez, Elena, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Ciències Biomèdiques [832]  
5.
1 p, 5.2 MB Prions in different organisms / Sierra Sillero, Gema ; Villaverde Corrales, Antonio, dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Microbiologia [816]  
6.
1 p, 2.3 MB β-N-methylamino-L-alanine (BMAA) produced by cyanobacteria as a possible cause of neurodegenerative deseases / Llorens Revull, Meritxell ; Luquín Fernández, M., (Marina), dir. (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Grau en Microbiologia [816]  
7.
1 p, 1.3 MB New proteins with prion-like domains involved in neurodegenerative disease / Domingo Pelegrin, Marina ; Ventura, Salvador, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Grau en Bioquímica [814]  
8.
1 p, 2.5 MB Identification of new neurodegenerative diseases / Díaz-Caballero, Marta ; Ventura, Salvador, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Grau en Bioquímica [814]  
9.
1 p, 3.2 MB Cholesterol homeostasis role in neurodegenerative diseases / Fernández Coll, Meritxell ; Saura Antolín, Carlos A., (Carlos Alberto), dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Grau en Biologia [812]  
10.
1 p, 3.8 MB Finding proteins with prion-like domains and their involvement in neurodegenerative diseases : FUS and HNRNPD / Carmona Ule, Nuria ; Ventura, Salvador, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Grau en Biotecnologia [815]  

Documentos de investigación : Encontrados 13 registros   1 - 10siguiente  ir al registro:
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.